These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 31651264

  • 1. Scaling up interventions: findings and lessons learned from an external evaluation of Niger's National Initiative to reduce postpartum hemorrhage.
    Mary M, Diop A, Sheldon WR, Yenikoye A, Winikoff B.
    BMC Pregnancy Childbirth; 2019 Oct 24; 19(1):379. PubMed ID: 31651264
    [Abstract] [Full Text] [Related]

  • 2. Postpartum hemorrhage prevention in Nepal: a program assessment.
    Rajbhandari SP, Aryal K, Sheldon WR, Ban B, Upreti SR, Regmi K, Aryal S, Winikoff B.
    BMC Pregnancy Childbirth; 2017 Jun 05; 17(1):169. PubMed ID: 28583092
    [Abstract] [Full Text] [Related]

  • 3. Advance distribution of misoprostol for prevention of postpartum hemorrhage (PPH) at home births in two districts of Liberia.
    Smith JM, Baawo SD, Subah M, Sirtor-Gbassie V, Howe CJ, Ishola G, Tehoungue BZ, Dwivedi V.
    BMC Pregnancy Childbirth; 2014 Jun 04; 14():189. PubMed ID: 24894566
    [Abstract] [Full Text] [Related]

  • 4. An Integrating Model for Rapid Reduction of Maternal Mortality Due to Primary Postpartum Haemorrhage - Novel Use of the Catalyst Approach to Public Health.
    Seim AR, Alassoum Z, Lalonde AB, Souley I.
    Afr J Reprod Health; 2019 Jun 04; 23(2):18-26. PubMed ID: 31433590
    [Abstract] [Full Text] [Related]

  • 5. Scaling Up Misoprostol to Prevent Postpartum Hemorrhage at Home Births in Mozambique: A Case Study Applying the ExpandNet/WHO Framework.
    Hobday K, Hulme J, Prata N, Wate PZ, Belton S, Homer C.
    Glob Health Sci Pract; 2019 Mar 22; 7(1):66-86. PubMed ID: 30926738
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Postpartum hemorrhage today: ICM/FIGO initiative 2004-2006.
    Lalonde A, Daviss BA, Acosta A, Herschderfer K.
    Int J Gynaecol Obstet; 2006 Sep 22; 94(3):243-53. PubMed ID: 16842791
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date.
    Smith JM, Gubin R, Holston MM, Fullerton J, Prata N.
    BMC Pregnancy Childbirth; 2013 Feb 20; 13():44. PubMed ID: 23421792
    [Abstract] [Full Text] [Related]

  • 13. Safety of a condom uterine balloon tamponade (ESM-UBT) device for uncontrolled primary postpartum hemorrhage among facilities in Kenya and Sierra Leone.
    Ramanathan A, Eckardt MJ, Nelson BD, Guha M, Oguttu M, Altawil Z, Burke T.
    BMC Pregnancy Childbirth; 2018 May 15; 18(1):168. PubMed ID: 29764416
    [Abstract] [Full Text] [Related]

  • 14. A cluster-randomized, non-inferiority trial comparing use of misoprostol for universal prophylaxis vs. secondary prevention of postpartum hemorrhage among community level births in Egypt.
    Anger HA, Dabash R, Hassanein N, Darwish E, Ramadan MC, Nawar M, Charles D, Breebaart M, Winikoff B.
    BMC Pregnancy Childbirth; 2020 May 24; 20(1):317. PubMed ID: 32448257
    [Abstract] [Full Text] [Related]

  • 15. Provider experiences with uterine balloon tamponade for uncontrolled postpartum hemorrhage in health facilities in Kenya.
    Natarajan A, Chavez J, Ahn R, Nelson BD, Eckardt M, Dulo L, Achieng E, Oguttu M, Tester K, Burke TF.
    Int J Gynaecol Obstet; 2015 Nov 24; 131(2):201-4. PubMed ID: 26277599
    [Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in India.
    Cook JR, Saxena K, Taylor C, Jacobs JL.
    BMC Health Serv Res; 2023 Mar 17; 23(1):267. PubMed ID: 36932411
    [Abstract] [Full Text] [Related]

  • 17. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in Benin and Mali.
    Dumont A, Bodin C, Hounkpatin B, Popowski T, Traoré M, Perrin R, Rozenberg P.
    BMJ Open; 2017 Sep 01; 7(9):e016590. PubMed ID: 28864699
    [Abstract] [Full Text] [Related]

  • 18. Initiating a novel therapy in preventing postpartum hemorrhage in rural India: a joint collaboration between the United States and India.
    Kodkany BS, Derman RJ, Goudar SS, Geller SE, Edlavitch SA, Naik VA, Patel A, Bellad MB, Patted SS.
    Int J Fertil Womens Med; 2004 Sep 01; 49(2):91-6. PubMed ID: 15188836
    [Abstract] [Full Text] [Related]

  • 19. A low-cost uterine balloon tamponade for management of postpartum hemorrhage: modeling the potential impact on maternal mortality and morbidity in sub-Saharan Africa.
    Herrick T, Mvundura M, Burke TF, Abu-Haydar E.
    BMC Pregnancy Childbirth; 2017 Nov 13; 17(1):374. PubMed ID: 29132342
    [Abstract] [Full Text] [Related]

  • 20. Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda.
    Lubinga SJ, Atukunda EC, Wasswa-Ssalongo G, Babigumira JB.
    PLoS One; 2015 Nov 13; 10(11):e0142550. PubMed ID: 26560140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.